Vivace Therapeutics Revenue and Competitors

Location

$70M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Vivace Therapeutics's estimated annual revenue is currently $697.5k per year.(i)
  • Vivace Therapeutics's estimated revenue per employee is $77,500
  • Vivace Therapeutics's total funding is $70M.

Employee Data

  • Vivace Therapeutics has 9 Employees.(i)
  • Vivace Therapeutics grew their employee count by 0% last year.

Vivace Therapeutics's People

NameTitleEmail/Phone
1
VP BiologyReveal Email/Phone
2
Director OperationsReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
CEO/PresidentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Vivace Therapeutics?

Vivace Therapeutics is a venture-backed, oncology-focused portfolio-based drug discovery and development company, based in San Mateo, California. Its programs include both small molecule programs targeting the YAP pathway, and bi-specific programs. For more information on the company, please visit the company website www.vivacetherapeutics.com. The company's scientific founders are Dr. Kun-liang Guan of UCSD, Dr. Bin Liu of UCSF and Dr. Sheng Ding of UCSF.

keywords:N/A

$70M

Total Funding

9

Number of Employees

$697.5k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vivace Therapeutics News

2022-04-06 - Vivace Therapeutics Presents New Preclinical Data Highlighting ...

Combination Treatment Demonstrates Enhanced Efficacy and Delayed Tumor Growth as Compared to Osimertinib Alone in EGFR Mutant Non-Small Cell...

2022-03-30 - Vivace Therapeutics to Present New Data from Preclinical ...

Vivace Therapeutics is a small molecule drug discovery and development company focused on targeting the Hippo pathway. The company is pursuing a...

2022-02-22 - Vivace Therapeutics Announces Issuance of New US Composition ...

About Vivace Therapeutics, Inc. Vivace Therapeutics is a small molecule drug discovery and development company focused on targeting the Hippo...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M9N/AN/A
#2
$0.7M90%N/A
#3
$0.7M90%N/A
#4
$0.7M9-25%N/A
#5
$0.7M90%N/A